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Abstract
Objectives: Andean and Tibetan high-altitude natives exhibit a high concentration of
nitric oxide (NO) in the lungs, suggesting that NO plays an adaptive role in offsetting
hypobaric hypoxia. We examined the exhaled NO concentration as well as partial
pressure of several additional high-altitude native populations in order to examine
the possibility that this putative adaptive trait, that is, high exhaled NO, is universal.
Methods: We recruited two geographically diverse highland native populations,
Tawang Monpa (TM), a Tibetan derived population in North-Eastern India (n = 95,
sampled at an altitude of ~3,200 m), and Peruvian Quechua from the highland Andes
(n = 412). The latter included three distinct subgroups defined as those residing at
altitude (Q-HAR, n = 110, sampled at 4,338 m), those born and residing at sea-level
(Q-BSL, n = 152), and those born at altitude but migrant to sea-level (Q-M, n = 150).
In addition, we recruited a referent sample of lowland natives of European ancestry
from Syracuse, New York. Fraction of exhaled NO concentrations were measured
using a NIOX NIMO following the protocol of the manufacturer.
Results: Partial pressure of exhaled nitric oxide (PENO) was significantly lower
(p < .05) in both high-altitude resident groups (TM = 6.2 ± 0.5 nmHg and Q-
HAR = 5.8 ± 0.5 nmHg), as compared to the groups measured at sea level
(USA = 14.6 ± 0.7 nmHg, Q-BSL = 18.9 ± 1.6 nmHg, and Q-M = 19.2 ± 1.7 nmHg).
PENO was not significantly different between TM and Q-HAR (p < .05).
Conclusion: In contrast to previous work, we found lower PENO in populations at
altitude (compared to sea-level) and no difference in PENO between Tibetan and
Andean highland native populations. These results do not support the hypothesis
that high nitric oxide in human lungs is a universal adaptive mechanism of highland
native populations to offset hypobaric hypoxia.
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1 | INTRODUCTION
Nitric oxide (NO) is found in various forms and locations in the body,
and is a key regulator of blood pressure and oxygen delivery
(Erusalimsky & Moncada, 2007; Knott & Bossy-Wetzel, 2010; Mon-
cada & Higgs, 2006). In the lung, NO is produced by nitric oxide
synthase (NOS) (See & Christiani, 2013; Guo, 2000) and plays a role in
regulating pulmonary blood flow by dilating pulmonary blood vessels
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(Hoit et al., 2005; Scherrer et al., 1996; Vaughan et al., 2003). Three
NOSs (Types I, II, and III) have been identified in the human lung. Type
I and III NOS are expressed primarily in neuronal and endothelial cells
of the normal human lung, respectively, and are dependent on intra-
cellular calcium for enzyme activation and NO production. Type II
NOS is the major NOS protein expressed in normal human airway epi-
thelium, which is calcium independent, and produces nanomolar levels
of NO (cf. Dweik et al., 1998). The cellular level of molecular oxygen
(O2) is an essential substrate for NO synthesis by NOS and therefore
NO production is generally decreased by low oxygen tension in tis-
sues (Le Cras & Mcmurtry, 2001). More specifically, NO levels
decreases as inspired oxygen levels decrease below ambient air, since
molecular O2 concentration determine the rate of NO synthesis
(Dweik et al., 1998).
It has been reported that individuals breathing varying levels of
inspired O2, NO levels were notably dependent on O2 concentration
(KmO2190μM), which is well within the physiological range
(0–250 μM). NOS Type II enzyme activity in vitro was similarly depen-
dent on molecular oxygen levels (KmO2135μM), revealing a means by
which O2 concentration affects NO levels in vivo (Dweik et al., 1998).
In this regard, Rengasamy and Johns (1996) have also suggested that
O2 substrate limitation may regulate NO production in conditions like
hypoxia (cf. Le Cras & Mcmurtry, 2001). As a consequence, it has been
observed that acute hypoxia reduced exhaled NO by 30% in animals
and almost 60% in humans (Le Cras & Mcmurtry, 2001).
Lung NO can be measured noninvasively as the fractional concen-
tration of exhaled NO (FENO), a clinical measurement which is com-
mon in the diagnosis of airway inflammation and/or asthma (Alving,
Weitzberg, & Lundberg, 1993; Franklin & Stick, 2008; Gustafsson,
Leone, Presson, Wilkund, & Moncada, 1991; Olin, Bake, & Torén,
2007; Travers et al., 2007). With respect to normobaric hypoxia,
FENO decreases by ~20% in humans on acute laboratory exposure to
normobaric hypoxia (inspired FiO2 = 0.05; time = 15–30 s) (Dweik
et al., 1998).
High-altitude native populations, such as those in the Andes and
Himalayas, are chronically exposed to hypobaric hypoxia and are the
descendants of populations who may have experienced past natural
selection in response to hypobaric hypoxia (Baker & Little, 1976;
Beall, 2006; Bigham et al., 2010; Monge, 1978; Moore, 2001). A study
by Beall et al. (2001) compared the FENO of Tibetan and Bolivian
high-altitude natives measured at altitude to a low-altitude reference
population from the United States. Tibetans had significantly higher
FENO than the Bolivians (Tibetans = 18.6 ppb and Aymara
Bolivians = 9.5 ppb), and both altitude-native groups showed higher
FENO than the lowland referent group from USA (7.4 ppb). The
higher FENO in Tibetans was also significantly associated with higher
pulmonary (Hoit et al., 2005) and forearm blood flow (Erzurum et al.,
2007). These findings support the hypothesis that high FENO is
related to the population adaptive response of Tibetans at altitude
and perhaps other altitude native populations as well. However, sev-
eral more recent studies have complicated this narrative. For example,
it also has been shown that Tibetan FENO decreases as altitude
increases, against the expectations of the NO adaptive hypothesis
(Ren et al., 2014). Likewise, in the Andes, several studies confuse the
overall conclusion that high pulmonary NO is an adaptive feature of
highland native populations. A study by Schwab et al found that
exhaled NO levels were similar between Bolivian high-altitude natives
and well-acclimatized individuals of European ancestry (Schwab et al.,
2008). Similarly, exhaled NO was found to be comparable between
Bolivian altitude-native and children of European ancestry born and
permanently residing at high altitude, and lower for both groups com-
pared to low-altitude children resident at sea-level (Stuber
et al., 2008).
Thus, a number of questions remain unanswered including: (a) Is
high exhaled NO concentration, relative to lowland groups, expressed
as a universal trait in all high-altitude native populations?; (b) Are there
meaningful quantitative differences in exhaled NO concentrations
between different highland native groups, for example, are exhaled
NO values higher in Tibetans versus other native groups?; and
(c) What role is played by developmental exposure to hypoxia versus
high-altitude genetic ancestry? In other words, does growth and
development at altitude affect the expression of exhaled NO concen-
tration as a putative altitude-adaptive trait? Here we report on
exhaled NO data collected by the same investigators using the same
measurement protocol in two widely dispersed highland native
populations residing at altitude (Tibetan Monpa and Peruvian Que-
chua) and compare these to referent data collected on lowland resi-
dent populations, including a group from Syracuse, USA, and two
groups of Peruvian Quechua residing in Lima, Peru, at sea-level. The
latter Peruvian groups differ by where they were born and raised
(sea-level versus altitude), which allows some interrogation of the
developmental question posed above.
2 | MATERIALS AND METHODS
2.1 | Study participants
Participants were healthy nonsmokers between the ages of 18–35.
Every effort was made to recruit equal numbers of healthy males and
females (nonpregnant, nonlactating) from each of the study groups
described below. Further, we did not include any anemic or polycy-
themic participant in our study. All the participants gave written
informed consent according to the guidelines established by the insti-
tutional review boards of three collaborating institutions, including
North-Eastern Hill University (NEHU, Meghalaya, India), Syracuse Uni-
versity (Syracuse, NY), and the Universidad Peruana Cayetano Heredia
(Lima, Peru). The study was also approved by the University of Michi-
gan (Ann Arbor, MI). The data that support the findings of this study
are available from the corresponding author upon reasonable request.
A total number of 670 individuals were recruited from three ethni-
cally and geographically diverse populations in India, Peru, and the
USA. The Peruvian participants were from a larger genetic study con-
ducted from 2012 to 2016 and these were individuals who self-
identified as Quechua high-altitude native. Quechua are one of the
principle Andean high-altitude ethnic groups with ancestry in the
region dating to at least 8,000–10,000 years before present
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(Rademaker et al., 2014). Three separate subgroups of Quechua par-
ticipants were recruited based on the goals of our previous study, and
these included the following: Quechua born and residing at sea level
(Q-BSL, n = 152), who were recruited and tested in Lima, Peru (100 m,
barometric pressure 761 mmHg, partial pressure of oxygen
[PO2] = 159.81 mmHg) and who had spent the entirety or majority
(>95%) of their lives living at sea level; Quechua-Migrants (Q-M,
n = 150), who were recruited and tested in Lima, but who were born
and raised above 3,000 m in highland Peru before migrating perma-
nently to Lima at some point during their lives; Quechua-High Altitude
Residents (Q-HAR, n = 110), who were recruited and tested in Cerro
de Pasco, Peru at 4,338 m above sea level (barometric pressure
462 mmHg, PO2 = 97.02 mmHg) and who had been born and raised
at altitudes above 3,000 m. The Indian participants self-identified as
Tawang Monpa (TM, n = 95), an indigenous Tibetan derived popula-
tion from Arunachal Pradesh, India, in the eastern most part of the
Himalaya. TM ancestry in the region is dated to ~1,000 years before
present following a migration from Southern Tibet (Elwin, 1959). All
TM participants were born and raised above 3,000 m, and mostly
engaged in sedentary urban lifestyle like cab driving. They were rec-
ruited and tested in Tawang Town, India at 3,200 m above sea level
(barometric pressure 535 mmHg, PO2 = 112.35 mmHg). The USA
participants (USA, n = 163) were from Syracuse, New York, (SYR)
and self-identified as Non-Hispanic White, born and raised at low
altitude. They were residents of Syracuse, NY, and students at Syra-
cuse University. They were recruited from undergraduate and gradu-
ate courses at Syracuse University and tested in Syracuse, NY at
100 m (barometric pressure 758 mmHg, PO2 = 159.18 mmHg).
2.2 | Anthropometry, hematology, and arterial
saturation measurements
For each participant, we measured height and weight and calculated
the body mass index (BMI, kg/m2). Transcutaneous arterial oxygen
saturation (SaO2) was measured at rest using a fingertip pulse oxime-
ter in India (CMS50EW, Neclife India) and a Nellcor N-560 bedside
pulse oximeter in the USA and Peru (Nellcor, Puritan Bennett,
Pleasantown, CA). Hemoglobin concentration was measured from a
fingertip blood drop using a Hemocue portable hemoglobin analyzer
(Hemocue®Angelholm, Sweden).
2.3 | Measurement of the exhaled nitric oxide
FENO was measured in exhaled air at an expiratory flow rate of
50 mL/s using the NIOX MINO®, portable, hand-held nitric oxide ana-
lyzer (Aerocrine AB, Solna, Sweden). This device relies on electro-
chemical sensor technology to detect exhaled NO values from 5 to
300 ppb (Alving et al., 2006). Values below 5 ppb are considered
below the lower limit of detection (LOD) of the instrument and values
above 300 ppb are above its upper detection limit. We recorded no
values above the upper limit, but when values fell below the lower
limit they were entered as 2.5 ppb for statistical analysis. Only 12 of
670 individuals, that is, 1.8% fell below the detection limit.
Importantly, results were similar whether these individuals were
treated as missing values or given a value of 2.5 ppb. The standard
exhalation time, as specified by the manufacturer, was 10s for persons
at or above 130 cm in height.
It has been observed that the mass flow through the flow regula-
tor falls with altitude and as a result apparently constant exhaled NO
readings in ppb across altitudes failed to reflect the much lower partial
pressures of exhaled NO at altitude (Hemmingsson, Horn, &
Linnarsson, 2009). Thus as a corrective measure, fractional exhaled
NO concentration (FENO) was converted to partial pressure of
exhaled NO (PENO) by using following formula: PENO = FENO ×
(barometric pressure – 47 mmHg)/1,000 (Beall, Strohl, Laskowski,
Hutte, & Erzurum, 2010; Hoit et al., 2005; Laskowski et al., 2010).
2.4 | Statistical analysis
All statistical analyses were performed using SPSS version 24.0 (SPSS
Inc., Chicago, IL) and/or STATA 11.1 (Stata Corp LP, TX). Prior to anal-
ysis, FENO measures were log-transformed to account for non-
normality as assessed by a Shapiro–Wilk normality test. In graphs and
tables, the nontransformed FENO values are presented. Group and
sex differences for most measured variables were assessed by
ANOVA applying the Walter-Duncan post hoc test to account for
multiple comparisons. Values are expressed as means ± standard
error, unless otherwise indicated. Statistical significance criteria were
set at p ≤ .05 for all tests.
3 | RESULTS
General participant characteristics by study group are presented in
Table 1. For nearly all variables there were significant sex differences
(p < .001), including height, weight, Hb, and BMI, as expected. In gen-
eral, there were also significant group differences for most measured
variables, which were expected given the geographic and ethnic diver-
sity of the participant populations. Rather than belabor these group
differences, here we simply highlight several important descriptive
features of the overall data set. First, the USA group was slightly
younger than the other study groups because they were sampled
from a US college population. The USA group was also taller, heavier,
and mostly leaner than the other study groups. Among the three Que-
chua groups, participants born and raised at sea-level were taller and
heavier, which could be due to myriad factors, but which is also con-
sistent with the restrictive effect of hypoxia on growth and develop-
ment (Beall, Baker, Baker, & Haas, 1977; Frisancho & Baker, 1970).
Hemoglobin concentration is also an important variable to consider as
it clearly marks hematological acclimatization to high altitude, at least
among the Andean participants. That is, the Q-HAR, who were high
altitude residents at 4,300 m, showed significantly higher [Hb] (17.6
± 0.19 g/dL) compared to all other study groups in consistent with
their chronic exposure to hypobaric hypoxia. The [Hb] of the TM
group is also noteworthy as this group was the other high-altitude res-
ident group sampled in the study. The TM group had a [Hb] of 14.1
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± 0.18 g/dL, which was not substantially higher than the sea-level res-
ident groups (Q-BSL = 13.8 ± 0.12 g/dL; Q-M = 13.7 ± 0.12;
USA = 13.6 ± 0.11 g/dL), despite living at 3,200 m altitude. This is
consistent with the broader literature on Tibetans, who characteristi-
cally show a blunted hemopoietic response to high altitude (Beall
et al., 1998).
Table 1 also shows the mean unadjusted FENO and PENO of the
different study groups. PENO was significantly (p < .05) lower in both
high-altitude resident groups (TM = 6.2 ± 0.5 nmHg and Q-
HAR = 5.8 ± 0.5 nmHg) as compared with the groups measured at sea
level (USA = 14.6 ± 0.7 nmHg, Q-BSL = 18.9 ± 1.6 nmHg, and Q-
M = 19.2 ± 1.7 nmHg). PENO was not significantly different between
TM and Q-HAR (p > .05). Similarly, unadjusted PENO values were not
significantly different between the three groups measured at sea level
(p > .05). PENO values were consistently higher in males as compared
with females in all five different study groups (Figure 1).
4 | DISCUSSION
This is the second study in the literature directly comparing exhaled
NO levels between two distinct high-altitude native populations
(Tibetan Monpa and Peruvian Quechua) using the same measurement
protocols and equipment. We found no differences in exhaled NO
concentration or partial pressure between Tibetan Monpa and Peru-
vian Q-HAR, unlike a previous study by Beall et al. (2001) that showed
substantially higher exhaled NO levels in Tibetan compared to Andean
(Bolivian) highland natives. Unlike the previous study by Beall et al.,
our two highland populations were measured at different altitudes
with different ambient PO2 levels (97.02 mmHg in Cerro de Pasco,
Peru and 112.35 mmHg in Tawang, India), but the overall significant
similarity between highland groups was interestingly unexpected
despite the altitude differences. Furthermore, both the highland
native populations in the present study (Monpa and Quechua) showed
lower exhaled NO partial pressure compared to referent populations
(USA, Q-M, and Q-BSL) measured at sea-level. Thus, our results are
not in agreement with previous studies which have argued that high
exhaled pulmonary NO is a central feature of Tibetan adaptation. This
may be due to technical/measurement differences between studies,
or due to the fact that exhaled pulmonary NO is not a valid marker of
the highland native adaptive response to hypobaric hypoxia.
In addition to our observations for high-altitude resident groups,
our results showed no differences in exhaled NO at sea level between
two groups of Quechua who differed by where they were born and
raised (sea-level versus above 3,000 m). This suggests that exhaled
NO is unaffected by growth and development at high-altitude, which
is a common mode of adaptive response to high altitude hypoxia
(Beall et al., 1977; Frisancho & Baker, 1970; Monge, 1978; Malik &
Singh, 1979). Finally, differences in exhaled NO between males and
females, and differences between the US reference group and the
Quechua sea-level groups, strongly suggest that much of the overall
variance that we observed in exhaled NO has little to do with the
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unmeasured local environmental conditions, for example, pollution
leading to lung inflammation (Dressel et al., 2008; Dweik et al., 2012;
Shang et al., 2018), or population level characteristics that were not
measured, for example, fitness-level (Green, Maiorana, O'Driscoll, &
Taylor, 2004; Jungersten, Ambring, Wall, & Wennmalm, 1997), diet
(Iijima et al., 2002; Larsen, Ekblom, Sahlin, Lundberg, & Weitzberg,
2006) and so forth.
The findings of this study only call into question the previous
notion that high exhaled pulmonary NO serves as a marker of pop-
ulation adaptation to high-altitude. The broader “NO-highland
native adaptive hypothesis”, which is well elaborated in a series of
papers (Beall et al., 2001; Erzurum et al., 2007; Hoit et al., 2005), is
different. This hypothesis relates to systemic or circulatory NO
and the clear role of NO in promoting increased blood flow,
whether in the lung or in working tissues. Previous studies do sug-
gest that NO accumulation in the bronchiolar gases is largely due
to local synthesis within the lung/airway (Dweik et al., 1998), but
it is unclear whether lung NO is also a measure of systemic
NO. Indeed, the work by Hoit et al., shows clear associations of
high concentration of exhaled NO with increased blood flow in the
lungs and high concentration of systemic/circulating NO with
increased blood flow in the forearm of Tibetans (Erzurum et al.,
2007; Hoit et al., 2005). Together, these earlier studies do provide
support for a broader adaptive hypothesis around systemic NO in
Tibetans. However, our results suggest that high level of exhaled
pulmonary NO is not a valid biomarker of this adaptive response.
More recent studies in Andean highland natives also support the
conclusion that caution is in order when interpreting exhaled NO
as a marker of the population adaptive response to high-altitude.
In two studies of Bolivian adults and children, exhaled NO was
similar between Aymara and well-acclimatized adults of European
ancestry living at high-altitude (Schwab et al., 2008), and was
lower in the Aymara children compared to low-altitude European
children resident at sea-level (Stuber et al., 2008).
A major limitation of our study is the validity of the measurement
system that was used to measure exhaled NO, that is, the NIOX
MINO system (Aerocrine, New Providence, NJ). Generally, there are
five sensor technologies that are used to detect gas-phase molecules
of NO: chemiluminescence, optical spectroscopy, mass spectrometry,
chromatography, and electrochemistry (Beall, Laskowski, & Erzurum,
2012). The previous study of Beall et al. (2001) on Tibetans measured
exhaled NO using a chemiluminescence sensor via the Sievers
NOA280i®measurement system (GE Analytical, Boulder, CO). The
Sievers NOA is considered the “gold-standard” measurement system
(Maniscalco et al., 2016), although the sensitivity to expired airflow
and the requirement that samples be collected in balloons makes this
a more technically challenging measurement system in a field setting.
The NIOXMINO uses a disposable electrochemical sensor and was
developed commercially for use in a clinical setting around the man-
agement of airway inflammation and asthma. The main issue with the
NIOX MINO system is that it cannot be calibrated, and indeed there
has been considerable debate in the literature around the external




F IGURE 1 Distribution, mean and standard error for partial pressure of exhaled nitric oxide across the study groups, by sex
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only one validation study exists to support use of the device under
low barometric pressure conditions (Beall et al., 2010; Gochicoa-
Rangel et al., 2016; Hemmingsson et al., 2009; Laskowski et al., 2010).
From this, it is clear that NIOX MINO measures are not interchange-
able with Siever's measures and it is fair to question the validity of the
results presented in this article.
In support of the NIOX device, a large number of studies have
been conducted to support the use of the NIOX MINO as a clinical
device at sea-level (Brody, Zhang, Kit, & Dillon, 2013; See & David,
2013; Olin et al., 2007; Travers et al., 2007). That is, the device shows
high repeatability and use of calibration for the chemiluminescence
analyzer (Brody et al., 2013; Choong & David, 2013; Olin et al., 2007;
Travers et al., 2007). Only one validation study supports the use of
the NIOX MINO at high altitude (Gochicoa-Rangel et al., 2016). The
latter study compared the NIOX MINO® to the Sievers NOA 280i®
and reported a high correlation (0.96, p < .001) between the two mea-
surement devices (participants were healthy nonsmoking adults of
Mexico City, Mexico, measured at an altitude of 2,240 m above sea
level). Further, NIOX measures were highly reproducible over five
consecutive days. However, the two devices showed relatively wide
limits of agreement (from −8.3 to 0.2 ppb), which brings into question
the external validity of the NIOX MINO when used at altitude.
Despite these wide limits of agreement (i.e., low external validity of
the NIOX), the Mexico study does support the use of the NIOX sys-
tem as an internally valid system for measurements made at the same
altitude between populations. Unfortunately, our populations were
measured at three different altitudes, and there are no formal publi-
shed studies to support NIOX validity between altitudes. However,
our preliminary testing of the device (data not shown) revealed no sig-
nificant differences in mean NIOX values when the same individual
was measured serially over 2 days at sea-level (n = 7 repeat measures),
~3,258 (n = 7 measures), and 4,295 m (n = 3 measures). Thus, taken
together, there is reasonable evidence to support use of the NIOX
measurement system for the purposes put forward in this article.
The other limitation of our study is that we were unable to
account for dietary NO concentrations as study confounders in the
manuscript. Although these confounders are potentially important in
influencing circulating NO, but previous study on Tibetans have
reported that water, tea, barley beer (<15 μM nitrite and <70 μM
nitrate) or foods generally contained low levels of nitrite or nitrate
(<0.4 mg/kg nitrite and <125 mg/kg nitrate). Hence, the dietary NO
from average daily food consumption was not at a level expected to
significantly increase circulating nitrate or nitrite (Erzurum
et al., 2007).
A final issue to consider with this study is our choice of a Monpa
population from North-eastern India as being representative of
Tibetan highland natives globally. This is especially true as Tibetan
natives in the literature are more commonly represented by
populations sampled in Western China (Beall et al., 2001; Erzurum
et al., 2007; Hoit et al., 2005), Lhasa, Tibet (Ren et al., 2014; Moore,
2001), or Sherpa in Nepal (Faoro et al., 2014; Winslow et al., 1989).
Indeed, our study of the Monpa Population, which is a relatively
isolated group in the politically sensitive district of Arunachal Pradesh,
India, is perhaps the first study of the biology and physiology of this
group. Culturally, the population is Buddhist and Tibetan, with the
world's second largest Tibetan monastery located in Tawang Town
where the study was conducted. Phenotypically, the Monpa in our
study lacked a hemopoietic response to hypobaric hypoxia, that is,
[Hb] levels were normal by sea-level standards, which is a trait that
strongly characterizes Tibetan altitude natives (Beall & Goldstein,
1990; Moore, 2001). Finally, our unpublished genetic analysis of this
population reveals that the TM are not genetically distinct from
Tibetan residents of Tibet. Rather, principal component analysis (PCA)
performed using ~100,000 single nucleotide polymorphisms (SNPs)
reveals that these two populations cluster together and that this
TM/Tibetan cluster is distinct from other South Asian and East Asian
populations included in the analysis. Thus, there is abundant evidence
here that Tawang Monpas, while geographically isolated, are repre-
sentative of the broader range of Tibetan derived populations living in
the Himalayas.
5 | CONCLUSION
Tibetans showed similar partial pressure of exhaled NO compared to
Peruvian Quechua, and both highland native groups showed lower
partial pressure of exhaled pulmonary NO compared to sea-level com-
parison groups measured at sea-level. Among the sea-level groups,
concentrations of exhaled NO were not related to developmental
exposure to high-altitude hypoxia. Therefore, we conclude that high
partial pressure and/or concentration of exhaled NO is not a universal
feature of highland natives and our results are not in agreement with
the notion that high level of exhaled NO is a useful biomarker of the
population level adaptive response to hypobaric hypoxia of Tibetans
or Andeans.
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